Diagnostic evaluation of metastatic rhabdomyosarcoma in effusion specimens
dc.contributor.author | Alderman, Megan A. | en_US |
dc.contributor.author | Thomas, Dafydd G. | en_US |
dc.contributor.author | Roh, Michael H. | en_US |
dc.date.accessioned | 2013-11-01T19:01:08Z | |
dc.date.available | 2015-01-05T13:54:45Z | en_US |
dc.date.issued | 2013-11 | en_US |
dc.identifier.citation | Alderman, Megan A.; Thomas, Dafydd G.; Roh, Michael H. (2013). "Diagnostic evaluation of metastatic rhabdomyosarcoma in effusion specimens." Diagnostic Cytopathology 41(11): 955-959. | en_US |
dc.identifier.issn | 8755-1039 | en_US |
dc.identifier.issn | 1097-0339 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/100330 | |
dc.publisher | Elsevier Saunders | en_US |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.subject.other | Myogenin | en_US |
dc.subject.other | Effusion | en_US |
dc.subject.other | Rhabdomyosarcoma | en_US |
dc.subject.other | Sarcoma | en_US |
dc.subject.other | Cytology | en_US |
dc.title | Diagnostic evaluation of metastatic rhabdomyosarcoma in effusion specimens | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Pathology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/100330/1/dc22987.pdf | |
dc.identifier.doi | 10.1002/dc.22987 | en_US |
dc.identifier.source | Diagnostic Cytopathology | en_US |
dc.identifier.citedreference | Furlong MA, Mentzel T, Fanburg‐Smith JC. Pleomorphic rhabdomyosarcoma in adults: a clinicopathologic study of 38 cases with emphasis on morphologic variants and recent skeletal muscle‐specific markers. Mod Pathol 2001; 14: 595 – 603. | en_US |
dc.identifier.citedreference | Afify AM, Al‐Khafaji BM, Paulino AF, Davila RM. Diagnostic use of muscle markers in the cytologic evaluation of serous fluids. Appl Immunihistochem Mol Morphol 2002; 10: 178 – 182. | en_US |
dc.identifier.citedreference | Longatto‐Filho A, Bisi H, Bortolan J, Granja NV, Lombardo V. Cytologic diagnosis of metastatic sarcoma in effusions. Acta Cytol 2003; 47: 317 – 318. | en_US |
dc.identifier.citedreference | Nelson AC, Singh C, Pambuccian SE. Cytological diagnosis of metastatic alveolar rhabdomyosarcoma in the ascitic fluid: Report of a case highlighting the diagnostic difficulties. Cytojournal 2012; 9: 9. | en_US |
dc.identifier.citedreference | Theunissen P, Cremers M, van der Meer S, Bot F, Bras J. Cytologic diagnosis of rhabdomyosarcoma in a child with a pleural effusion. A case report. Acta cytol 2004; 48: 249 – 253. | en_US |
dc.identifier.citedreference | Thiryayi SA, Rana DN, Roulson J, Crosbie P, Woodhead M, Eyden BP, et al. Diagnosis of alveolar rhabdomyosarcoma in effusion cytology: A diagnostic pitfall. Cytopathology 2010; 21: 273 – 275. | en_US |
dc.identifier.citedreference | Cessna MH, Zhou H, Perkins SL, Tripp SR, Layfield L, Daines C, et al. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics. Am J Surg Pathol 2001; 25: 1150 – 1157. | en_US |
dc.identifier.citedreference | Kumar S, Perlman E, Harris CA, Raffeld M, Tsokos M. Myogenin is a specific marker for rhabdomyosarcoma: An immunohistochemical study in paraffin‐embedded tissues. Mod Pathol 2000; 13: 988 – 993. | en_US |
dc.identifier.citedreference | Morgenstern DA, Rees H, Sebire NJ, Shipley J, Anderson J. Rhabdomyosarcoma subtyping by immunohistochemical assessment of myogenin: tissue array study and review of the literature. Pathol Oncol Res 2008; 14: 233 – 238. | en_US |
dc.identifier.citedreference | Berkes CA, Tapscott SJ. MyoD and the transcriptional control of myogenesis. Semin Cell Dev Biol 2005; 16: 585 – 595. | en_US |
dc.identifier.citedreference | Chivukula M, Saad R. Metastatic sarcomas, melanoma, and other non‐epithelial neoplasms. In: Shidham VB, Atkinson BF, editors. Cytopathologic diagnosis of serous fluids. Philadelphia: Elsevier Saunders; 2007. p 147 – 156. | en_US |
dc.identifier.citedreference | Hasteh F, Lin GY, Weidner N, Michael CW. The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions. Cancer Cytopathol 2010; 118: 90 – 96. | en_US |
dc.identifier.citedreference | Kishore B, Khare P, Gupta RJ, Gupta C, Khare V. A rare case of paratesticular pleomorphic rhabdomyosarcoma diagnosed by fine needle aspiration: A case report. Diagn Cytopathol 2010; 38: 121 – 126. | en_US |
dc.identifier.citedreference | Hostein I, Andraud‐Fregeville M, Guillou L, Terrier‐Lacombe MJ, Deminiere C, Ranchere D, et al. Rhabdomyosarcoma: Value of myogenin expression analysis and molecular testing in diagnosing the alveolar subtype. An analysis of 109 paraffin‐embedded specimens. Cancer 2004; 101: 2817 – 2824. | en_US |
dc.identifier.citedreference | Castelino‐Prabhu S, Ali SZ. “Strap cells” in primary prostatic rhabdomyosarcoma in a child. Diagn Cytopathol 2010; 38: 505 – 506. | en_US |
dc.identifier.citedreference | Klijanienko J, Caillaud JM, Orbach D, Brisse H, Lagace R, Sastre‐Gareau X. Cyto‐histological correlations in primary, recurrent, and metastatic bone and soft tissue osteosarcoma. Institut Curie's experience. Diagn Cytopathol 2007; 35: 270 – 275. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.